Total Payments
$585,108
2024 Payments
$60,828
Companies
48
Transactions
1,504
Medicare Patients
1,907
Medicare Billing
$308,739
Payment Breakdown by Category
Other$340,210 (58.1%)
Research$92,278 (15.8%)
Consulting$87,225 (14.9%)
Food & Beverage$34,999 (6.0%)
Travel$30,278 (5.2%)
Gifts$60.09 (0.0%)
Education$58.78 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300,059 | 168 | 51.3% |
| Unspecified | $92,278 | 55 | 15.8% |
| Consulting Fee | $87,225 | 43 | 14.9% |
| Honoraria | $38,231 | 24 | 6.5% |
| Food and Beverage | $34,999 | 1,038 | 6.0% |
| Travel and Lodging | $30,278 | 145 | 5.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,920 | 1 | 0.3% |
| Gift | $60.09 | 20 | 0.0% |
| Education | $58.78 | 10 | 0.0% |
Payments by Type
General
$492,831
1,449 transactions
Research
$92,278
55 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $99,757 | 145 | $0 (2023) |
| Neurelis, Inc. | $98,790 | 79 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $52,887 | 111 | $0 (2022) |
| Greenwich Biosciences, Inc. | $44,803 | 81 | $0 (2021) |
| NEUROPACE, INC. | $43,917 | 110 | $0 (2024) |
| UCB, Inc. | $42,146 | 167 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $28,448 | 78 | $0 (2024) |
| SK Life Science, Inc. | $25,121 | 90 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $24,442 | 23 | $0 (2019) |
| Marinus Pharmaceuticals, Inc. | $20,036 | 47 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60,828 | 230 | NEUROPACE, INC. ($16,487) |
| 2023 | $60,741 | 231 | UCB, Inc. ($21,933) |
| 2022 | $122,819 | 208 | Neurelis, Inc. ($65,901) |
| 2021 | $53,268 | 210 | Neurelis, Inc. ($14,850) |
| 2020 | $83,171 | 182 | Eisai Inc. ($27,063) |
| 2019 | $87,838 | 177 | EISAI INC. ($27,616) |
| 2018 | $54,293 | 119 | Sunovion Pharmaceuticals Inc. ($20,767) |
| 2017 | $62,152 | 147 | Eisai Inc. ($22,666) |
All Payment Transactions
1,504 individual payment records from CMS Open Payments — Page 1 of 61
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/28/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $34.02 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 12/20/2024 | SpringWorks Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $22.60 | General |
| 12/17/2024 | Monteris Medical Corporation | Neuroblate (Device) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: Neuroblate | ||||||
| 12/17/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: EPILEPSY | ||||||
| 12/13/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $32.74 | General |
| Category: Neurology | ||||||
| 12/12/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: Neurology | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: PAIN | ||||||
| 12/10/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $49.67 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $82.73 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/09/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $45.83 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/08/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Food and Beverage | In-kind items and services | $177.76 | General |
| Category: Epilepsy | ||||||
| 12/08/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $148.73 | General |
| Category: NEUROLOGY | ||||||
| 12/08/2024 | Monteris Medical Corporation | Neuroblate (Device) | Food and Beverage | In-kind items and services | $127.95 | General |
| Category: Neuroblate | ||||||
| 12/08/2024 | BIOCODEX, INC. | DIACOMIT (Drug) | Food and Beverage | In-kind items and services | $84.74 | General |
| Category: Antiepileptic | ||||||
| 12/07/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $56.02 | General |
| Category: Neurology | ||||||
| 12/06/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $31.91 | General |
| 12/05/2024 | UCB, Inc. | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: Neurology | ||||||
| 12/04/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $33.78 | General |
| 11/25/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 11/20/2024 | AQUESTIVE THERAPEUTICS, INC. | LIBERVANT (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: Neurology | ||||||
| 11/12/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Neurology | ||||||
| 11/12/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $18.25 | General |
| Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| AN OPEN-LABEL, SINGLE-DOSE, PHARMACOKINETICS STUDY OF VALTOCO WITH OPEN-LABEL SAFETY PERIOD IN PEDIATRIC SUBJECTS WITH EPILEPSY | Neurelis, Inc. | $59,735 | 5 |
| Response Study | NEUROPACE, INC. | $17,458 | 44 |
| RNS Adolescents with Epilepsy study | NEUROPACE, INC. | $14,685 | 5 |
| Retro Chart Review for under 18 patients study | NEUROPACE, INC. | $400.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 488 | 646 | $157,695 | $79,290 |
| 2022 | 7 | 529 | 620 | $165,901 | $79,573 |
| 2021 | 9 | 510 | 620 | $144,808 | $82,239 |
| 2020 | 8 | 380 | 466 | $129,062 | $67,637 |
Total Patients
1,907
Total Services
2,352
Medicare Billing
$308,739
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 363 | $68,404 | $31,638 | 46.3% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2023 | 65 | 72 | $32,039 | $20,685 | 64.6% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 41 | 44 | $11,012 | $7,344 | 66.7% |
| 95708 | Measurement of brain wave activity (eeg), 12-26 hours | Office | 2023 | 41 | 44 | $20,056 | $6,818 | 34.0% |
| 95719 | Measurement of brain wave activity (eeg), 12-26 hours with health care professional review and report | Office | 2023 | 39 | 42 | $9,694 | $5,776 | 59.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 26 | $8,562 | $3,352 | 39.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $3,808 | $2,619 | 68.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 24 | $4,075 | $1,013 | 24.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 15 | $45.00 | $44.10 | 98.0% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2022 | 89 | 93 | $39,836 | $26,515 | 66.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 241 | $47,348 | $20,908 | 44.2% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2022 | 64 | 66 | $18,164 | $10,546 | 58.1% |
| 95708 | Measurement of brain wave activity (eeg), 12-26 hours | Office | 2022 | 64 | 67 | $33,800 | $9,149 | 27.1% |
| 95719 | Measurement of brain wave activity (eeg), 12-26 hours with health care professional review and report | Office | 2022 | 58 | 59 | $13,825 | $8,554 | 61.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 73 | $12,866 | $3,840 | 29.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 18 | 21 | $63.00 | $62.19 | 98.7% |
| 95812 | Measurement of brain wave (eeg) activity, 41-60 minutes | Office | 2021 | 75 | 82 | $32,213 | $24,005 | 74.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 142 | 220 | $46,060 | $19,612 | 42.6% |
| 95708 | Measurement of brain wave activity (eeg), 12-26 hours, unmonitored | Office | 2021 | 53 | 61 | $29,852 | $15,841 | 53.1% |
| 95700 | Continuous measurement of brain wave activity (eeg), administered in person by eeg technologist | Office | 2021 | 53 | 58 | $14,805 | $9,790 | 66.1% |
| 95719 | Continuous measurement of brain wave activity (eeg), 12-26 hours, with health care professional analysis, interpretation and report | Office | 2021 | 49 | 54 | $11,975 | $8,031 | 67.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 46 | $7,900 | $2,957 | 37.4% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 43 | 43 | $1,247 | $1,247 | 100.0% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 41 | 42 | $714.00 | $714.00 | 100.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 13 | 14 | $42.00 | $42.00 | 100.0% |
About Dr. Steven Wolf, MD
Dr. Steven Wolf, MD is a Neurology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487645693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Wolf, MD has received a total of $585,108 in payments from pharmaceutical and medical device companies, with $60,828 received in 2024. These payments were reported across 1,504 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($300,059).
As a Medicare-enrolled provider, Wolf has provided services to 1,907 Medicare beneficiaries, totaling 2,352 services with total Medicare billing of $308,739. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location New York, NY
- Active Since 11/04/2005
- Last Updated 05/30/2014
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1487645693
Products in Payments
- VALTOCO (Drug) $98,790
- Fycompa (Drug) $86,835
- APTIOM (Drug) $52,959
- Fintepla (Drug) $49,340
- Epidiolex (Drug) $44,803
- ACTHAR (Biological) $36,074
- RNS Neurostimulator Kit (Device) $33,707
- EPIDIOLEX (Drug) $28,292
- ZTALMY (Drug) $18,536
- XCOPRI (Drug) $18,249
- ONFI (Drug) $18,236
- SYMPAZAN (Drug) $17,252
- OXTELLAR XR (Drug) $16,981
- RNS System (Device) $10,209
- Brineura (Biological) $7,671
- Banzel (Drug) $6,516
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $5,409
- Cenobamate (Drug) $5,388
- Neuroblate (Device) $3,804
- VNS Therapy (Device) $2,486
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in New York
Dr. Stephen Krieger, Md, MD
Neurology — Payments: $1.6M
Neurology $1.6M
Dr. David Dodick, M.d, M.D
Neurology — Payments: $765,174
Neurology $765,174
Dr. David Simpson, M.d, M.D
Neurology — Payments: $638,492
Neurology $638,492
Dr. Alexander Shtilbans, Md, Ph.d, MD, PH.D
Neurology — Payments: $550,165
Neurology $550,165
Dr. Fred Lublin, M.d, M.D
Neurology — Payments: $549,390
Neurology $549,390
Dr. Alcibiades Rodriguez, Md, MD
Neurology — Payments: $540,659
Neurology $540,659